Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Sales | 5,191,600 | 4,175,600 | 3,607,400 | 3,643,800 | 3,322,500 |
| Cost of Goods | 1,586,300 | 1,255,800 | 1,125,300 | 1,302,800 | 1,224,700 |
| Gross Profit | 3,668,300 | 2,919,800 | 2,732,900 | 2,341,000 | 2,374,200 |
| Operating Expenses | 2,066,200 | 1,755,800 | 1,560,600 | 1,758,100 | 1,268,600 |
| Operating Income | 1,539,400 | 1,164,800 | 921,800 | 583,700 | 829,900 |
| Other Income | 59,600 | 165,100 | 158,900 | 11,300 | 13,500 |
| Pre-tax Income | 1,599,000 | 1,329,900 | 1,080,700 | 595,000 | 843,400 |
| Income Tax | 471,700 | 390,400 | 319,700 | 184,500 | 301,900 |
| Net Income Continuous | 1,127,300 | 939,500 | 761,000 | 410,500 | 541,500 |
| Net Income Discontinuous | 0 | 0 | 0 | 233,200 | 16,700 |
| Net Income | $1,127,300 | $939,500 | $761,000 | $643,700 | $558,200 |
| EPS Basic Total Ops | 1.04 | 0.85 | 0.69 | 0.58 | 0.50 |
| EPS Basic Continuous Ops | 1.06 | 0.84 | 0.69 | 0.37 | 0.46 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.21 | 0.01 |
| EPS Diluted Total Ops | 1.02 | 0.84 | 0.69 | N/A | 0.48 |
| EPS Diluted Continuous Ops | 1.02 | 0.84 | 0.69 | N/A | 0.46 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
| EBITDA(a) | $1,786,900 | $1,394,100 | $1,125,800 | $794,000 | $1,007,600 |